Synergy Pharmaceuticals (SGYP) shares have had an excellent run over the past one month, gaining more than 40%. SGYP shares have now crossed $5. On Monday, the stock closed at $5.06. Despite the excellent run, SGYP shares still look undervalued. Based on my price target, there is still significant upside from current levels.